股票/基金 实时行情 股吧

简称:渤海股份 代码:000605


会计年度:2011-12-31收入分布
项目名称主营业务收入主营业务成本主营业务毛利毛利率
医药生产销售38,648,254.0029,709,933.008,938,321.0023.13

会计年度:2011-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
复方甘草酸苷2,974,600.001,981,600.00993,000.0033.38
纤溶酶3,115,900.002,768,700.00347,200.0011.14
盐酸芦氟沙星2,648,300.001,814,700.00833,600.0031.48
盐酸曲美他嗪原料2,877,000.002,491,400.00385,600.0013.40

会计年度:2010-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
医药生产销售33,745,757.1227,430,882.48----
100u纤溶酶5,571,764.204,561,217.601,010,546.60--
医药商业批发--------
复方甘草酸苷3,716,540.582,266,284.751,450,255.83--
盐酸芦氟沙星6,304,797.954,271,537.002,033,260.95--

会计年度:2010-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
纤溶酶2,604,000.001,733,500.00870,500.0033.43
盐酸芦氟沙星胶囊1,873,100.001,121,800.00751,300.0040.11

会计年度:2009-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
盐酸芦氟沙星胶囊5,309,100.003,946,500.00----

    5/9 转到